4.7 Article

Frequency Evaluation of the Interleukin-6-174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Hepcidin and Iron in Health and Disease

Elizabeta Nemeth et al.

Summary: Hepcidin, secreted by hepatocytes, controls the activity of ferroportin to regulate plasma iron concentrations and total body iron content. Iron loading and inflammation increase hepcidin levels, while erythropoietic stimulation and pregnancy suppress its levels. Hepcidin deficiency leads to iron overload, while hepcidin excess causes iron-restrictive anemias. Developing hepcidin diagnostics and therapeutics will improve the treatment of iron disorders.

ANNUAL REVIEW OF MEDICINE (2023)

Article Genetics & Heredity

A comprehensive meta-analysis comprising 149 case-control studies to investigate the association between IL-6 gene rs1800795 polymorphism and multiple disease risk

Md Harun-Or-Roshid et al.

Summary: Through a statistical meta-analysis, we identified an association between IL-6 gene rs1800795 polymorphism and multiple disease risks. The results showed a significant correlation between IL-6 -174G/C polymorphism and overall disorder risk, coronary artery disease, inflammatory diseases, and rheumatoid arthritis. This study provides strong evidence for IL-6 gene as a prognostic biomarker for CAD, inflammatory disease, ischemic stroke, and rheumatoid arthritis.
Letter Biochemistry & Molecular Biology

Hereditary hemochromatosis: The complex role of the modifier genes

Giorgio Biasiotto et al.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2023)

Review Rheumatology

Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus

Desh Nepal et al.

Summary: This narrative review examines the role of IL-6 in murine and human SLE, and its potential use as a targeted therapy in future studies. Currently, there are no registered clinical trials assessing IL-6 inhibition in SLE.

RHEUMATOLOGY (2023)

Review Medicine, General & Internal

Disentangling the Pathogenesis of Systemic Lupus Erythematosus: Close Ties between Immunological, Genetic and Environmental Factors

Henry Sutanto et al.

Summary: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease that attacks various organ systems with a range of clinical manifestations. This review discusses the molecular and cellular aspects of SLE pathogenesis, focusing on the interaction between the immune system, genetics, and the environment and how they trigger the various clinical manifestations of SLE.

MEDICINA-LITHUANIA (2023)

Article Hematology

Hemochromatosis classification: update and recommendations by the BIOIRON Society

Domenico Girelli et al.

Summary: Hemochromatosis is a genetically heterogenous disorder characterized by uncontrolled intestinal iron absorption leading to iron overload and potentially life-threatening complications. Recent research has identified mutations in at least 5 genes as the main cause of the disease, affecting hepcidin production or action.

BLOOD (2022)

Article Medicine, Research & Experimental

Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis

Nada Starcevic Cizmarevic et al.

Summary: Increasing evidence supports the potential role of iron metabolism in multiple sclerosis (MS). However, a meta-analysis of 7 studies conducted in Caucasian populations found no significant association between the C282Y and H63D polymorphisms in the HFE gene and MS risk. Further studies are needed to evaluate the contribution of HFE and other genetic variants associated with iron regulation in the development and progression of MS.

BIOMEDICAL REPORTS (2022)

Article Rheumatology

Association of interleukin-6 promoter polymorphism with rheumatoid arthritis: a meta-analysis with trial sequential analysis

Ming Shao et al.

Summary: The meta-analysis found that the IL-6 -174G/C gene polymorphism is associated with an increased risk of RA in Asians, but not in Caucasians. There is no association between IL-6 -572G/C gene polymorphism and the risk of RA.

CLINICAL RHEUMATOLOGY (2022)

Review Medicine, Research & Experimental

Interleukin-6 signalling as a valuable cornerstone for molecular medicine (Review)

Maria Trovato et al.

Summary: Interleukin-6 (IL-6) has been studied for nearly 40 years for its biological capabilities, primarily in inflammatory and cognitive processes. It interacts with the IL-6 receptor complex and plays a crucial role in signal transduction. Abnormal production of IL-6 has been associated with diseases such as autoimmune thyroid disorders and SARS-CoV-2 infection.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Immunology

Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus

Chris Wincup et al.

Summary: SLE is characterized by autoantibodies against nuclear components and oxidative stress. Recent studies suggest abnormal iron homeostasis and mitochondrial dysfunction in SLE. Therapeutic strategies targeting iron and mitochondria may be novel treatment options in the future.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Article Allergy

Interleukin Polymorphisms and Predisposition of Systemic Lupus Erythematosus: A Meta-Analysis

Zongqing Liu et al.

Summary: This meta-analysis found that interleukin polymorphisms, particularly IL-1, IL-4, IL-6, and IL-10, may impact the predisposition of SLE. The results varied among different ethnicities, with positive findings observed in Asians for certain polymorphisms and in Caucasians for others.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)

Article Medicine, General & Internal

Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank

Luke C. Pilling et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Hematology

-174 G>C IL-6 polymorphism and primary iron overload in male patients

Walter F. Tetzlaff et al.

ANNALS OF HEMATOLOGY (2018)

Review Rheumatology

New insights into the immunopathogenesis of systemic lupus erythematosus

George C. Tsokos et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Letter Hematology

Hereditary hemochromatosis: The same old song

Isabella Zanella et al.

BLOOD CELLS MOLECULES AND DISEASES (2015)

Article Cell Biology

IL-6 in Inflammation, Immunity, and Disease

Toshio Tanaka et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Letter Rheumatology

Targeting IL-6 promoter polymorphism-174G/C should be dependent on ethnicity

Wang-Dong Xu et al.

CLINICAL RHEUMATOLOGY (2012)

Review Medicine, General & Internal

MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis

Iain B. McInnes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Biochemistry & Molecular Biology

Two to Tango: Regulation of Mammalian Iron Metabolism

Matthias W. Hentze et al.

Article Gastroenterology & Hepatology

Iron overload and immunity

Graca Porto et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Article Immunology

Patterns of nonclassical MHC antigen presentation

Ted H. Hansen et al.

NATURE IMMUNOLOGY (2007)

Review Rheumatology

Interleukin 6: from bench to bedside

Norihiro Nishimoto et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)

Article Rheumatology

Manifestation of rheumatoid arthritis in a patient with hereditary haemochromatosis

Dirk Wernicke et al.

RHEUMATOLOGY INTERNATIONAL (2006)

Article Multidisciplinary Sciences

Direct recognition by αβ cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function

PS Rohrlich et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)